Fasting reduces tear production

Article

Fasting significantly reduces the amount of tears produced by the eye and increases the osmolarity of the tears, according to new research.

Fasting significantly reduces the amount of tears produced by the eye and increases the osmolarity of the tears, according to new research published in Eye & Contact Lens: Science & Clinical Practice. Fasting does not deteriorate the parameters of corneal topography or ocular aberrations in people who are healthy, however.

The study authors conducted a prospective controlled study of 29 eyes in 29 healthy men (mean age, 27.8 ± 5.9 years; range, 20 to 47 years). All of the men underwent corneal topography via a placido disc corneal topography and aberrometry device (OPD-Scan II, Nidek) before their ophthalmic examinations. Researchers used an osmometer (OcuSense, Tear Lab) to measure tear osmolarity. They also evaluated ocular surface disease index (OSDI) scores, tear break-up time (BUT), Schirmer I test and lissamine green staining.

The investigators took measurements between 4 pm and 5 pm before and during Ramadan and compared them using paired sample t test, considering a P value of less than 0.05 as statistically significant.

The researchers found:

  • The mean tear osmolarity values were 285.6 ± 8.2 mOsm/L in nonfasting periods and 293.3 ± 16.0 mOsm/L in fasting periods.
  • The mean Schirmer I values were 14.8 ± 6.0 mm in nonfasting periods and 10.6 ± 5.3 mm in fasting periods.
  • Tear osmolarity, OSDI and Oxford grading scores significantly increased during the fasting period compared with the nonfasting period.
  • Schirmer I values and IOP decreased during the fasting period compared with the nonfasting period.
  • No significant differences occurred in tear BUT, keratometry values and corneal aberration measurements in nonfasting periods compared with fasting periods.

To read an abstract of the study, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.